16-2103870-C-T

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_001009944.3(PKD1):​c.8187G>A​(p.Ser2729Ser) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0011 in 1,588,834 control chromosomes in the GnomAD database, including 22 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0051 ( 16 hom., cov: 28)
Exomes 𝑓: 0.00071 ( 6 hom. )

Consequence

PKD1
NM_001009944.3 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: -5.68

Publications

1 publications found
Variant links:
Genes affected
PKD1 (HGNC:9008): (polycystin 1, transient receptor potential channel interacting) This gene encodes a member of the polycystin protein family. The encoded glycoprotein contains a large N-terminal extracellular region, multiple transmembrane domains and a cytoplasmic C-tail. It is an integral membrane protein that functions as a regulator of calcium permeable cation channels and intracellular calcium homoeostasis. It is also involved in cell-cell/matrix interactions and may modulate G-protein-coupled signal-transduction pathways. It plays a role in renal tubular development, and mutations in this gene cause autosomal dominant polycystic kidney disease type 1 (ADPKD1). ADPKD1 is characterized by the growth of fluid-filled cysts that replace normal renal tissue and result in end-stage renal failure. Splice variants encoding different isoforms have been noted for this gene. Also, six pseudogenes, closely linked in a known duplicated region on chromosome 16p, have been described. [provided by RefSeq, Oct 2008]
PKD1 Gene-Disease associations (from GenCC):
  • autosomal dominant polycystic kidney disease
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
  • polycystic kidney disease 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Laboratory for Molecular Medicine, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • autosomal recessive polycystic kidney disease
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • Caroli disease
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.75).
BP6
Variant 16-2103870-C-T is Benign according to our data. Variant chr16-2103870-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 257015.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-5.68 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00514 (730/142118) while in subpopulation AFR AF = 0.0177 (667/37728). AF 95% confidence interval is 0.0166. There are 16 homozygotes in GnomAd4. There are 332 alleles in the male GnomAd4 subpopulation. Median coverage is 28. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 16 AD,AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PKD1NM_001009944.3 linkc.8187G>A p.Ser2729Ser synonymous_variant Exon 23 of 46 ENST00000262304.9 NP_001009944.3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PKD1ENST00000262304.9 linkc.8187G>A p.Ser2729Ser synonymous_variant Exon 23 of 46 1 NM_001009944.3 ENSP00000262304.4 P98161-1

Frequencies

GnomAD3 genomes
AF:
0.00511
AC:
725
AN:
141994
Hom.:
16
Cov.:
28
show subpopulations
Gnomad AFR
AF:
0.0176
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00190
Gnomad ASJ
AF:
0.00147
Gnomad EAS
AF:
0.00156
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00662
Gnomad NFE
AF:
0.000168
Gnomad OTH
AF:
0.00567
GnomAD2 exomes
AF:
0.00174
AC:
415
AN:
239026
AF XY:
0.00138
show subpopulations
Gnomad AFR exome
AF:
0.0203
Gnomad AMR exome
AF:
0.00113
Gnomad ASJ exome
AF:
0.00234
Gnomad EAS exome
AF:
0.00199
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000131
Gnomad OTH exome
AF:
0.000851
GnomAD4 exome
AF:
0.000705
AC:
1020
AN:
1446716
Hom.:
6
Cov.:
34
AF XY:
0.000599
AC XY:
431
AN XY:
719428
show subpopulations
African (AFR)
AF:
0.0205
AC:
678
AN:
33030
American (AMR)
AF:
0.00118
AC:
52
AN:
43906
Ashkenazi Jewish (ASJ)
AF:
0.00148
AC:
38
AN:
25750
East Asian (EAS)
AF:
0.000897
AC:
35
AN:
39000
South Asian (SAS)
AF:
0.000163
AC:
14
AN:
85708
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
50860
Middle Eastern (MID)
AF:
0.00197
AC:
8
AN:
4066
European-Non Finnish (NFE)
AF:
0.000101
AC:
112
AN:
1104976
Other (OTH)
AF:
0.00140
AC:
83
AN:
59420
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.450
Heterozygous variant carriers
0
52
104
157
209
261
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
26
52
78
104
130
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00514
AC:
730
AN:
142118
Hom.:
16
Cov.:
28
AF XY:
0.00483
AC XY:
332
AN XY:
68788
show subpopulations
African (AFR)
AF:
0.0177
AC:
667
AN:
37728
American (AMR)
AF:
0.00190
AC:
27
AN:
14216
Ashkenazi Jewish (ASJ)
AF:
0.00147
AC:
5
AN:
3402
East Asian (EAS)
AF:
0.00157
AC:
7
AN:
4468
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4086
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
9538
Middle Eastern (MID)
AF:
0.00709
AC:
2
AN:
282
European-Non Finnish (NFE)
AF:
0.000168
AC:
11
AN:
65582
Other (OTH)
AF:
0.00561
AC:
11
AN:
1962
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
30
60
90
120
150
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00294
Hom.:
4

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Sep 20, 2019
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Apr 25, 2025
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Polycystic kidney disease Benign:1
-
Department of Pathology and Laboratory Medicine, Sinai Health System
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

The PKD1 p.Ser2729Ser variant was identified in 2 of 164 proband chromosomes (frequency: 0.012) from individuals or families with ADPKD (Garcia-Gonzalez 2007). This variant was identified in the 1000 Genomes Project in 41 of 5000 chromosomes (frequency: 0.0082), NHLBI GO Exome Sequencing Project in 2 of 8532 European American alleles (frequency: 0.000234412), and 45 of 4324 African American alleles (frequency: 0.010407031), Exome Aggregation Consortium database (August 8, 2016) in 218 (4 homozygous) of 83288 chromosomes (frequency: 0.002617) in the following populations: African in 177 of 6580 chromosomes (frequency: 0.0269), Latino in 11 of 7048 chromosomes (frequency: 0.001561), European (Non-Finnish) in 15 of 45562 chromosomes (frequency: 0.0003292), South Asian in 1 of 13388 chromosomes (frequency: 0.00007469), East Asian in 14 of 5720 (frequency: 0.002448) but was not seen in European (Finnish) and Other populations, increasing the likelihood that this may be a low frequency benign variant in certain populations of origin. In addition we cannot be certain that data from control databases is specific to PKD1 and not from one of the six PKD1 pseudogenes. The variant was also identified in dbSNP (ID: rs28674911) as “With Benign allele”, ClinVar and Clinvitae (benign, by Prevention Genetics), ADPKD Mutation Database (Likely neutral). The p.Ser2729Ser variant is not expected to have clinical significance because it does not result in a change of amino acid and is not located in a known consensus splice site. In addition, in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer, and HumanSpliceFinder) do not predict a difference in splicing. In summary, based on the above information, this variant meets our laboratory criteria to be classified as benign. -

Autosomal dominant polycystic kidney disease Benign:1
Jan 01, 2019
Molecular Genetics of Inherited Kidney Disorders Laboratory, Garvan Institute of Medical Research
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:research

- -

not provided Benign:1
Apr 01, 2020
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 17574468) -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.75
CADD
Benign
0.86
DANN
Benign
0.53
PhyloP100
-5.7
RBP_binding_hub_radar
0.92
RBP_regulation_power_radar
2.0
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs28674911; hg19: chr16-2153871; COSMIC: COSV51922822; COSMIC: COSV51922822; API